Phase I Clinical Trial of Induced Pluripotent Stem Cell-derived Extracellular Vesicles Combined With Temporal Muscle Flap Application in Promoting Intracranial and Extracranial Blood Flow Reconstruction in Patients With Moyamoya Disease
Latest Information Update: 28 Jul 2025
At a glance
- Drugs NouvSoma002 01 (Primary)
- Indications Arterial occlusive disorders
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 28 Jul 2025 New trial record